Literature DB >> 27104781

Renal extracellular vesicles: from physiology to clinical application.

E E Morrison1, M A Bailey2, J W Dear1.   

Abstract

Urinary extracellular vesicles (uEVs) are released from all regions of the kidney's nephron and from other cells that line the urinary tract. Extracellular vesicles retain proteomic and transcriptomic markers specific to their cell of origin and so represent a potential reservoir for kidney disease biomarker discovery. Exosomes, a subtype of uEVs, are distinguished from other vesicles by features related to their biogenesis within cells: mature multi-vesicular bodies fuse with the cellular membrane to liberate exosomes into the extracellular space. uEVs represent a novel cell signalling mechanism because they can be shuttled to a recipient cell and, through a number of proposed mechanisms, affect the recipient cell's proteome and function. Here we review the current evidence for uEV signalling along the nephron, their role in health and disease of the kidney, and their potential for clinical translation as biomarkers and therapeutics.
© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27104781      PMCID: PMC5063943          DOI: 10.1113/JP272182

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  111 in total

Review 1.  Therapeutic applications of mesenchymal stem cells to repair kidney injury.

Authors:  Hiroshi Asanuma; Daniel R Meldrum; Kirstan K Meldrum
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

Review 2.  Rationale of mesenchymal stem cell therapy in kidney injury.

Authors:  Susanne V Fleig; Benjamin D Humphreys
Journal:  Nephron Clin Pract       Date:  2014-09-24

3.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.

Authors:  Stefano Gatti; Stefania Bruno; Maria Chiara Deregibus; Andrea Sordi; Vincenzo Cantaluppi; Ciro Tetta; Giovanni Camussi
Journal:  Nephrol Dial Transplant       Date:  2011-02-15       Impact factor: 5.992

4.  Stromal cells protect against acute tubular injury via an endocrine effect.

Authors:  Baoyuan Bi; Roland Schmitt; Malika Israilova; Hitoshi Nishio; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

5.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.

Authors:  Yanhua Tian; Suping Li; Jian Song; Tianjiao Ji; Motao Zhu; Gregory J Anderson; Jingyan Wei; Guangjun Nie
Journal:  Biomaterials       Date:  2013-12-15       Impact factor: 12.479

6.  A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation.

Authors:  J R Woollard; R Punyashtiti; S Richardson; T V Masyuk; S Whelan; B Q Huang; D J Lager; J vanDeursen; V E Torres; V H Gattone; N F LaRusso; P C Harris; C J Ward
Journal:  Kidney Int       Date:  2007-05-23       Impact factor: 10.612

7.  Isolation of urinary extracellular vesicles from Tamm- Horsfall protein-depleted urine and their application in the development of a lectin-exosome-binding assay.

Authors:  Maja Kosanović; Miroslava Janković
Journal:  Biotechniques       Date:  2014-09-01       Impact factor: 1.993

8.  Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity.

Authors:  Krzysztof Bryniarski; Wlodzimierz Ptak; Asha Jayakumar; Kerstin Püllmann; Michael J Caplan; Arthit Chairoungdua; Jun Lu; Brian D Adams; Emilia Sikora; Katarzyna Nazimek; Susanna Marquez; Steven H Kleinstein; Panjamaporn Sangwung; Yasuko Iwakiri; Eric Delgato; Frank Redegeld; Bart R Blokhuis; Jacek Wojcikowski; Anna Wladyslawa Daniel; Tom Groot Kormelink; Philip W Askenase
Journal:  J Allergy Clin Immunol       Date:  2013-05-31       Impact factor: 10.793

9.  Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo.

Authors:  Monica Agromayor; Juan Martin-Serrano
Journal:  J Biol Chem       Date:  2006-06-07       Impact factor: 5.157

10.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.

Authors:  Kenneth W Witwer; Edit I Buzás; Lynne T Bemis; Adriana Bora; Cecilia Lässer; Jan Lötvall; Esther N Nolte-'t Hoen; Melissa G Piper; Sarada Sivaraman; Johan Skog; Clotilde Théry; Marca H Wauben; Fred Hochberg
Journal:  J Extracell Vesicles       Date:  2013-05-27
View more
  17 in total

1.  Current Methods for the Isolation of Urinary Extracellular Vesicles.

Authors:  Serena Maggio; Emanuela Polidori; Paola Ceccaroli; Andrea Cioccoloni; Vilberto Stocchi; Michele Guescini
Journal:  Methods Mol Biol       Date:  2021

2.  Exosome production and its regulation of EGFR during wound healing in renal tubular cells.

Authors:  Xiangjun Zhou; Wei Zhang; Qisheng Yao; Hao Zhang; Guie Dong; Ming Zhang; Yutao Liu; Jian-Kang Chen; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-29

3.  Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.

Authors:  Robin S Chirackal; Muthuvel Jayachandran; Xiangling Wang; Samuel Edeh; Zejfa Haskic; Majuran Perinpam; Timothy M Halling; Ramila Mehta; Marcelino E Rivera; John C Lieske
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

4.  Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation.

Authors:  Lin-Li Lv; Ye Feng; Yi Wen; Wei-Jun Wu; Hai-Feng Ni; Zuo-Lin Li; Le-Ting Zhou; Bin Wang; Jian-Dong Zhang; Steven D Crowley; Bi-Cheng Liu
Journal:  J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 10.121

Review 5.  Nanomedicines for renal disease: current status and future applications.

Authors:  Nazila Kamaly; John C He; Dennis A Ausiello; Omid C Farokhzad
Journal:  Nat Rev Nephrol       Date:  2016-10-31       Impact factor: 28.314

6.  [Value of podocalyxin levels in urinary extracellular vesicles for diagnosis of diabetic nephropathy].

Authors:  Fan Wu; Yunyin Chen; Hua Xiao; Ziliang Zou; Jing Ning; Haishan Chen; Hequn Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

7.  Podocyte-Released Migrasomes in Urine Serve as an Indicator for Early Podocyte Injury.

Authors:  Ying Liu; Shan Li; Weiwei Rong; Caihong Zeng; Xiaodong Zhu; Qilin Chen; Limin Li; Zhi-Hong Liu; Ke Zen
Journal:  Kidney Dis (Basel)       Date:  2020-10-23

Review 8.  Urinary extracellular vesicles. A promising shortcut to novel biomarker discoveries.

Authors:  Karina Barreiro; Harry Holthofer
Journal:  Cell Tissue Res       Date:  2017-04-20       Impact factor: 5.249

Review 9.  Therapeutic application of extracellular vesicles in kidney disease: promises and challenges.

Authors:  Lin-Li Lv; Wei-Jun Wu; Ye Feng; Zuo-Lin Li; Tao-Tao Tang; Bi-Cheng Liu
Journal:  J Cell Mol Med       Date:  2017-10-30       Impact factor: 5.310

Review 10.  Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics.

Authors:  Mayooran Shanmuganathan; Jeff Vughs; Michela Noseda; Costanza Emanueli
Journal:  Front Physiol       Date:  2018-11-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.